Chicago's United Center Partners with Senorita and RYTHM for THC Beverages
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy RYM?
Chicago's United Center has entered a new multi-year partnership with Senorita and RYTHM to make THC beverages available at concerts and live events. "This partnership is a major milestone for the city of Chicago, and we are proud to partner with the United Center to offer Illinois' leading THC beverages," said Ben Kovler, RYTHM, Inc. Chairman and Interim CEO. "Bringing Senorita and RYTHM to the United Center reflects a simple truth: consumers want non-alcoholic options, and leading venues are responding. The United Center is one of the world's premier venues and continues to set the standard for live entertainment with the introduction of these modern, responsible options."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RYM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RYM
About RYM
RYTHM, Inc., formerly Agrify Corporation, is a provider of branded innovative solutions for the cannabis and hemp industries. The Company’s portfolio of brands includes RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, & Shine, Doctor Solomon’s and Good Green in thousands of physical locations and online channels. The Company’s portfolio of consumer-packaged goods brands includes Senorita brand which offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror well-known cocktails like a margarita in four flavors, including classic Lime JalapeNo Margarita, Mango Margarita, Paloma and Ranch Water. Senorita offers a low-sugar, low-calorie alternative to alcoholic beverages and is available at retailers, including Total Wine, ABC Fine Wine & Spirits, and Binny’s in 11 U.S. states and Canada. Its comprehensive extraction product line includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Price Decline: As of April 21, Green Thumb Industries' shares have fallen 10% year-to-date, primarily due to slow progress in reforming federal marijuana restrictions in the U.S., which has dampened investor confidence and affected market performance.
- Analyst Optimism: Despite challenges, analysts maintain an average price target of $18.50 per share for Green Thumb, over 100% above the current price, reflecting market expectations for future marijuana law reforms and recognition of the company's potential.
- Profitability Improvement: Green Thumb has been profitable since 2019, operating 113 retail stores and 20 manufacturing facilities; although revenue grew only 3.3% last year, the newly introduced flat-fee licensing model is expected to significantly enhance future profitability.
- Change in Licensing Model: The company announced it will pay a flat $70 million in licensing fees annually, increasing only with the Consumer Price Index, which is expected to help boost incremental earnings and drive further profit growth.
See More
- Analyst Price Targets: Analysts have set an average price target of $18.50 for Green Thumb Industries, which is over 100% higher than its current trading price, indicating strong market optimism for its future growth potential.
- Licensing Fee Change: On April 1, Green Thumb announced a shift from revenue-based royalties to a fixed annual licensing fee of $70 million, which is expected to significantly enhance the company's profitability moving forward.
- Profitability Boost: Although revenue grew only 3.3% last year, the flat-fee licensing structure will likely allow most incremental revenue to flow directly to profits, further driving earnings growth in upcoming reports.
- Market Environment Challenges: Despite facing challenges from slow progress on federal marijuana reform in the U.S., analysts remain bullish on Green Thumb's performance, suggesting a clear path for potential stock price doubling in the future.
See More
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
- Agreement Revision: RYTHM has amended its trademark and recipe license agreements with a subsidiary of Green Thumb Industries, establishing a fixed annual cash fee of $70 million, subject to yearly increases tied to the consumer price index, indicating a positive outlook for future revenues.
- Brand Usage Rights: The revised agreements cover the use of certain brand intellectual property under existing agreements, ensuring RYTHM can continue leveraging its intellectual property in future brand strategies, thereby enhancing its market competitiveness.
- Effective Date: These amendments will take effect on April 1, 2026, meaning RYTHM will secure a stable cash inflow over the next few years, contributing to its financial stability and long-term growth.
- Market Reaction: RYTHM's stock surged 35.08% in pre-market trading to $24.72, reflecting a positive market response to the agreement revision, which may boost investor confidence in the company's future growth potential.
See More
- Fee Structure Adjustment: Green Thumb Industries has amended its brand licensing agreements with RYTHM's subsidiaries, transitioning from revenue-based fees to a fixed annual fee of $70 million, which is expected to provide stable cash flow and enhance financial predictability for the company.
- Brand Expansion Commitment: The founder of Green Thumb emphasized the company's dedication to expanding the market reach of RYTHM brands, having successfully built a strong brand presence over the past decade, and will continue to drive long-term growth for these brands.
- Market Positioning Advantage: This agreement amendment not only solidifies Green Thumb's partnership with RYTHM but also enhances its competitive position in the rapidly growing U.S. cannabis consumer goods market, likely attracting more consumers.
- Employee and Market Impact: With approximately 5,000 employees across 14 U.S. markets, the amended agreements will help Green Thumb maintain stable operations and growth in future market expansions, further solidifying its leadership position in the cannabis industry.
See More
- Financial Highlights: RYTHM reported a GAAP EPS of -$6.63 for Q4, indicating significant losses; however, revenue surged by 167.5% year-over-year to $10.7 million, showcasing strong momentum in revenue growth.
- Revenue Growth Analysis: The revenue increase was primarily driven by the launch of new products and rising market demand, which not only enhanced the company's market share but also laid the groundwork for future profitability.
- Market Reaction: Despite the substantial revenue growth, the negative EPS may pressure investor confidence, leading to stock price volatility and reflecting market concerns regarding the company's financial health.
- Future Outlook: RYTHM must implement effective measures in upcoming quarters to improve profitability in order to maintain competitiveness in a growing market, especially in light of potential investor skepticism.
See More









